Georgia MSSP Information
ACO Name and Location
PQN – Georgia, LLC
602 Dogwood Trail
Suite F
Tyrone, GA 30290
ACO Primary Contact
JIM SAMS, MD
(470) 588-9480
JSAMS@PRIVIAHEALTH.COM
Organizational Information
ACO participants:
ACO Participants | ACO Participant in Joint Venture |
---|---|
AIM MEDICAL ASSOCIATES, PC | Y |
ANU RAVIKANTH MD LLC | Y |
BAINBRIDGE MEDICAL ASSOCIATES PC | Y |
BCG MEDICAL GROUP LLC | Y |
BOHLER FAMILY PRACTICE PC | Y |
CAPSTONE MEDICAL CLINIC LLC | Y |
DR. JAY VELIYATH, INC | Y |
FAMILY MEDICINE SPECIALIST, PC | Y |
FAMILY PRACTICE ASSOICATES LLC | Y |
HEARTLAND HEALTHCARE PC | Y |
HIGH MOUNTAIN HEALTHCARE, LLC | Y |
HILLANDALE INTERNAL MEDICINE P.C. | Y |
HOWARD S ELLISON MD PC | Y |
JOHN A KELLER MD PC | Y |
JORGE AMADOR MD LLC | Y |
LAWRENCE A. ADJEI, APMC | Y |
LIFETIME MEDICAL CENTER PC | Y |
LINDA L CASTEEL MD PC | Y |
MCINTOSH CLINIC, PC | Y |
MCINTOSH TRAIL FAMILY PRACTICE | Y |
PEACHTREE MEDICAL CENTER | Y |
PERISSEIA PHYSICIANS, LLC | Y |
PERRY FAMILY PRACTICE LLC | Y |
PORT MEDICAL MANAGEMENT INC | Y |
PRIME CARE MEDICAL SERVICES INC | Y |
PROFESSIONAL PARK MEDICAL SERVICES PC | Y |
PRIVIA MEDICAL GROUP OF GEORGIA, LLC | Y |
PRIVIA MEDICAL GROUP SOUTH GEORGIA, LLC | Y |
RANDY B CRONIC, M.D. PC | Y |
ROBERT G. CARTER | Y |
SOUTHCOAST MEDICAL GROUP LLC | Y |
SUZANNE L. NUNN, MD PC | Y |
TATE MEDICAL ASSOCIATES, LLC | Y |
THE VERANDA, PC | Y |
THOMASVILLE FAMILY MEDICINE CENTER | Y |
YONAH MOUNTAIN FAMILY PRACTICE | Y |
ACO Governing Body:
Member’s Voting Power –Expressed as a percentage or number | |||||
---|---|---|---|---|---|
Last Name | First Name | Title/Position | Membership Type | ACO Participant Legal Business Name/DBA, if Applicable | |
SAMS | JIM | EXECUTIVE | 8.34% | ACO EXECUTIVE | PRIVIA HEALTH |
CHESLOCK | AMY | EXECUTIVE | 8.33% | ACO EXECUTIVE | PRIVIA HEALTH |
GEE | MICHAEL | PHYSICIAN | 9.38% | ACO PARTICIPANT REPRESENTATIVE | PRIVIA MEDICAL GROUP – GEORGIA |
KEMP | CHARLES | PHYSICIAN | 9.37% | ACO PARTICIPANT REPRESENTATIVE | PRIVIA MEDICAL GROUP – GEORGIA |
COLE | FRANK | PHYSICIAN | 9.37% | ACO PARTICIPANT REPRESENTATIVE | PRIVIA MEDICAL GROUP – GEORGIA |
STUBBS | JOSEPH | PHYSICIAN | 9.38% | ACO PARTICIPANT REPRESENTATIVE | PRIVIA MEDICAL GROUP – GEORGIA |
WEEKS | ROBERT | PHYSICIAN | 9.38% | ACO PARTICIPANT REPRESENTATIVE | PRIVIA MEDICAL GROUP – GEORGIA |
WHITE | GARRETT | PHYSICIAN | 9.37% | ACO PARTICIPANT REPRESENTATIVE | PRIVIA MEDICAL GROUP – GEORGIA |
BOHLKE | W SCOTT | PHYSICIAN | 9.37% | ACO PARTICIPANT REPRESENTATIVE | PRIVIA MEDICAL GROUP – GEORGIA |
COOPER | WILLIAM | PHYSICIAN | 9.38% | ACO PARTICIPANT REPRESENTATIVE | PRIVIA MEDICAL GROUP – GEORGIA |
THOMAS, JR | JAMES | PATIENT | 8.33% | MEDICARE BENEFICIARY REPRESENTATIVE | N/A |
Key ACO Clinical and Administrative Leadership:
ACO Executive | JAMES SAMS, MD |
Medical Director | JAMES SAMS, MD |
Compliance Officer | DANA FIELDS |
Quality Assurance/Improvement Officer | GWEN WYLES |
Associated Committees and Committee Leadership:
Committee Name | Committee Leader Name & Position |
---|---|
PQN – GEORGIA, LLC BOARD | JAMES SAMS, MD, CHAIR |
MEMBERSHIP COMMITTEE | FRANK COLE, MD, CHAIR |
STEERING COMMITTEE | CHARLES KEMP, MD, CHAIR |
CLINICAL PERFORMANCE COMMITTEE | FRANK COLE, MD, CHAIR |
FINANCE COMMITTEE | AMY CHESLOCK, CHAIR |
COMPLIANCE COMMITTEE | JAMES SAMS, MD, CHAIR |
Types of ACO participants, or combinations of participants, that formed the ACO:
- ACO professionals in a group practice arrangement
Shared Savings and Losses
Amount of Shared Savings/Losses
- Second Agreement Period
- Performance Year 2020, $8,748,128
- First Agreement Period
- Performance Year 2019, $5,618,143
- Performance Year 2018, $6,112,852
- Performance Year 2017, $4,954,482
Shared Savings Distribution
- Second Agreement Period
- Performance Year 2020
- Proportion invested in infrastructure: 30%
- Proportion invested in redesigned care processes/resources: 10%
- Proportion of distribution to ACO participants: 60%
- Performance Year 2020
- First Agreement Period
- Performance Year 2019
- Proportion invested in infrastructure: 30%
- Proportion invested in redesigned care processes/resources: 10%
- Proportion of distribution to ACO participants: 60%
- Performance Year 2018
- Proportion invested in infrastructure: 30%
- Proportion invested in redesigned care processes/resources: 10%
- Proportion of distribution to ACO participants: 60%
- Performance Year 2017
- Proportion invested in infrastructure: 30%
- Proportion invested in redesigned care processes/resources: 10%
- Proportion of distribution to ACO participants: 60%
- Performance Year 2019
Quality Performance Results
2020 Quality Performance Results:
ACO# | Measure Name | Rate | ACO Mean |
---|---|---|---|
ACO 43 | Ambulatory Sensitive Condition Acute Composite (AHRQ Preventive Quality Indicator (PQI # 91)) | 0.96 | 0.95 |
ACO 13 | Falls: Screening for Future Fall Risk | 95.16 | 84.97 |
ACO 14 | Preventive Care and Screening: Influenza Immunization | 80.38 | 76.03 |
ACO 17 | Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention | 91.67 | 81.67 |
ACO 18 | Preventive Care and Screening: Screening for Clinical Depression and Follow-Up Plan | 78.01 | 71.46 |
ACO-19 | Colorectal Cancer Screening | 71.00 | 72.59 |
ACO-20 | Breast Cancer Screening | 80.25 | 74.05 |
ACO-42 | Statin Therapy for the Prevention and Treatment of Cardiovascular Disease | 80.57 | 83.37 |
ACO-27 | Diabetes: Hemoglobin A1c Poor Control | 12.45 | 14.70 |
ACO-28 | Controlling High Blood Pressure | 82.53 | 72.87 |
For Previous Years’ Financial and Quality Performance Results, Please Visit data.cms.gov
Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size. The Centers for Medicare & Medicaid Services (CMS) also waived the requirement for ACOs to field a CAHPS for ACOs survey for PY 2020 through the Physician Fee Schedule Final Rule for Calendar Year 2021. Additionally, CMS reverted ACO-8 Risk-Standardized, All Condition Readmission and ACO-38 Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions to pay-for-reporting, given the impact of the coronavirus disease 2019 (COVID-19) public health emergency (PHE) on these measures.